Effect of the PAF antagonists, CV-3988 and L-652, 731 on the pulmonary and hematological responses to guinea pig anaphylaxis
- 31 August 1988
- journal article
- research article
- Published by Elsevier in Pharmacological Research Communications
- Vol. 20 (9) , 785-798
- https://doi.org/10.1016/s0031-6989(88)80717-3
Abstract
No abstract availableThis publication has 26 references indexed in Scilit:
- Interference by the novel PAF-acether antagonist WEB 2086 with the bronchopulmonary responses to PAF-acether and to active and passive anaphylactic shock in guinea-pigsEuropean Journal of Pharmacology, 1987
- Effects of PAF-acether and structural analogues on platelet activation and bronchoconstriction in guinea-pigsEuropean Journal of Pharmacology, 1986
- Protection by two ginkgolides, BN-52020 and BN-52021, against guinea-pig lung anaphylaxisPharmacological Research Communications, 1986
- Interference of BN 52021 (ginkgolide B) with the bronchopulmonary effects of PAF-acether in the guinea-pigEuropean Journal of Pharmacology, 1986
- Role of Platelet-Activating Factor-Acether in Mediating Guinea Pig AnaphylaxisScience, 1986
- Inhibition of antigen-induced lung anaphylaxis in the guinea-pig by BN 52021 a new specific paf-acether receptor antagonist isolated from Ginkgo bilobaInflammation Research, 1986
- Hyperventilation-Induced Bronchoconstriction in Guinea PigsInternational Archives of Allergy and Immunology, 1985
- Acetyl glyceryl ether phosphorylcholine (AGEPC). A putative mediator of cardiac anaphylaxis in the guinea pig.Circulation Research, 1984
- CV-3988 - A specific antagonist of platelet activating factor (PAF)Life Sciences, 1983
- Platelet-activating factor induces a platelet-dependent bronchoconstriction unrelated to the formation of prostaglandin derivativesEuropean Journal of Pharmacology, 1980